{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:01:27Z","timestamp":1784070087805,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023MH340"],"award-info":[{"award-number":["ZR2023MH340"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870848"],"award-info":[{"award-number":["81870848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong University Multidisciplinary Research and Innovation Team of Young Scholars","award":["2020QNQT019"],"award-info":[{"award-number":["2020QNQT019"]}]},{"name":"the Fundamental Research Funds of Chinese Academy of Medical Sciences","award":["2019-RC-HL-026"],"award-info":[{"award-number":["2019-RC-HL-026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11064-025-04379-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:50:00Z","timestamp":1743857400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting UAF1 Alleviate Neurotoxicity by Inhibiting APP\/NLRP3 Axis-Mediated Pyroptosis and Apoptosis"],"prefix":"10.1007","volume":"50","author":[{"given":"Ling","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.4103\/1673-5374.391311","volume":"19","author":"B Hu","year":"2024","unstructured":"Hu B, Zhang J, Huang J, Luo B, Zeng X, Jia J (2024) NLRP3\/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer\u2019s disease. Neural Regen Res 19:2400\u20132410. https:\/\/doi.org\/10.4103\/1673-5374.391311","journal-title":"Neural Regen Res"},{"key":"4379_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, Tousseyn T, De Strooper B, Thal DR (2023) Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol 145:175\u2013195. https:\/\/doi.org\/10.1007\/s00401-022-02528-y","journal-title":"Acta Neuropathol"},{"key":"4379_CR3","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","volume":"30","author":"LL Friker","year":"2020","unstructured":"Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, Geyer M, Heneka MT (2020) beta-Amyloid clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep 30:3743\u20133754e3746. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.025","journal-title":"Cell Rep"},{"key":"4379_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/cns.12697","volume":"23","author":"C Huang","year":"2017","unstructured":"Huang C, Dong D, Jiao Q, Pan H, Ma L, Wang R (2017) Sarsasapogenin-AA13 ameliorates Abeta-induced cognitive deficits via improving neuroglial capacity on Abeta clearance and antiinflammation. CNS Neurosci Ther 23:498\u2013509. https:\/\/doi.org\/10.1111\/cns.12697","journal-title":"CNS Neurosci Ther"},{"key":"4379_CR5","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","volume":"13","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chai Y, Fu Y, Wang Y, Zhang Y, Zhang X, Zhu L, Miao M, Yan T (2021) Salidroside ameliorates Alzheimer\u2019s disease by targeting NLRP3 Inflammasome-Mediated pyroptosis. Front Aging Neurosci 13:809433. https:\/\/doi.org\/10.3389\/fnagi.2021.809433","journal-title":"Front Aging Neurosci"},{"key":"4379_CR6","doi-asserted-by":"publisher","first-page":"e13142","DOI":"10.1111\/bpa.13142","volume":"33","author":"RT Vontell","year":"2023","unstructured":"Vontell RT, de Rivero Vaccari JP, Sun X, Gultekin SH, Bramlett HM, Dietrich WD, Keane RW (2023) Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer\u2019s disease. Brain Pathol 33:e13142. https:\/\/doi.org\/10.1111\/bpa.13142","journal-title":"Brain Pathol"},{"key":"4379_CR7","doi-asserted-by":"publisher","first-page":"17841","DOI":"10.1038\/s41598-023-45220-1","volume":"13","author":"C Nopparat","year":"2023","unstructured":"Nopparat C, Boontor A, Kutpruek S, Govitrapong P (2023) The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines. Sci Rep 13:17841. https:\/\/doi.org\/10.1038\/s41598-023-45220-1","journal-title":"Sci Rep"},{"key":"4379_CR8","doi-asserted-by":"publisher","first-page":"1400544","DOI":"10.3389\/fnagi.2024.1400544","volume":"16","author":"X Meng","year":"2024","unstructured":"Meng X, Song Q, Liu Z, Liu X, Wang Y, Liu J (2024) Neurotoxic beta-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons. Front Aging Neurosci 16:1400544. https:\/\/doi.org\/10.3389\/fnagi.2024.1400544","journal-title":"Front Aging Neurosci"},{"key":"4379_CR9","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","volume":"238","author":"J Li","year":"2020","unstructured":"Li J, Zhuang L, Luo X, Liang J, Sun E, He Y (2020) Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice. Exp Brain Res 238:2603\u20132614. https:\/\/doi.org\/10.1007\/s00221-020-05916-6","journal-title":"Exp Brain Res"},{"key":"4379_CR10","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1084\/jem.20170180","volume":"214","author":"Z Yu","year":"2017","unstructured":"Yu Z, Song H, Jia M, Zhang J, Wang W, Li Q, Zhang L, Zhao W (2017) USP1-UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses. J Exp Med 214:3553\u20133563. https:\/\/doi.org\/10.1084\/jem.20170180","journal-title":"J Exp Med"},{"key":"4379_CR11","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1038\/s41467-020-19939-8","volume":"11","author":"H Song","year":"2020","unstructured":"Song H, Zhao C, Yu Z, Li Q, Yan R, Qin Y, Jia M, Zhao W (2020) UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression. Nat Commun 11:6042. https:\/\/doi.org\/10.1038\/s41467-020-19939-8","journal-title":"Nat Commun"},{"key":"4379_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2131\/jts.47.349","volume":"47","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhang M, Wang J, Wang Q (2022) Knockdown of UAF1 alleviates sevoflurane-induced cognitive impairment and neurotoxicity in rats by inhibiting pro-inflammatory signaling and oxidative stress. J Toxicol Sci 47:349\u2013357. https:\/\/doi.org\/10.2131\/jts.47.349","journal-title":"J Toxicol Sci"},{"key":"4379_CR13","doi-asserted-by":"publisher","first-page":"167553","DOI":"10.1016\/j.bbadis.2024.167553","volume":"1871","author":"Y Liu","year":"2025","unstructured":"Liu Y, Qin K, Dou K, Ren J, Hou B, Xie A (2025) TMEM106B knockdown exhibits a neuroprotective effect in Parkinson\u2019s disease models via regulating autophagy-lysosome pathway. Biochim Biophys Acta Mol Basis Dis 1871:167553. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167553","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4379_CR14","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1080\/21655979.2022.2047406","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao M (2022) Suppression of NOD-like receptor protein 3 inflammasome activation and macrophage M1 polarization by Hederagenin contributes to Attenuation of sepsis-induced acute lung injury in rats. Bioengineered 13:7262\u20137276. https:\/\/doi.org\/10.1080\/21655979.2022.2047406","journal-title":"Bioengineered"},{"key":"4379_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20:165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"key":"4379_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12017-024-08815-z","volume":"27","author":"X Zhuang","year":"2024","unstructured":"Zhuang X, Lin J, Song Y, Ban R, Zhao X, Xia Z, Wang Z, Zhang G (2024) The interplay between accumulation of Amyloid-Beta and Tau proteins, PANoptosis, and inflammation in Alzheimer\u2019s disease. Neuromolecular Med 27:2. https:\/\/doi.org\/10.1007\/s12017-024-08815-z","journal-title":"Neuromolecular Med"},{"key":"4379_CR17","doi-asserted-by":"publisher","first-page":"109941","DOI":"10.1016\/j.neuropharm.2024.109941","volume":"252","author":"RM McManus","year":"2024","unstructured":"McManus RM, Latz E (2024) NLRP3 inflammasome signalling in Alzheimer\u2019s disease. Neuropharmacology 252:109941. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109941","journal-title":"Neuropharmacology"},{"key":"4379_CR18","doi-asserted-by":"publisher","first-page":"1414956","DOI":"10.3389\/fnagi.2024.1414956","volume":"16","author":"X Yu","year":"2024","unstructured":"Yu X, Tao J, Xiao T, Duan X (2024) P-hydroxybenzaldehyde protects caenorhabditis elegans from oxidative stress and beta-amyloid toxicity. Front Aging Neurosci 16:1414956. https:\/\/doi.org\/10.3389\/fnagi.2024.1414956","journal-title":"Front Aging Neurosci"},{"key":"4379_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11064-022-03782-y","volume":"48","author":"S Guo","year":"2023","unstructured":"Guo S, Lei Q, Guo H, Yang Q, Xue Y, Chen R (2023) Edaravone attenuates Abeta 1-42-Induced inflammatory damage and ferroptosis in HT22 cells. Neurochem Res 48:570\u2013578. https:\/\/doi.org\/10.1007\/s11064-022-03782-y","journal-title":"Neurochem Res"},{"key":"4379_CR20","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1172\/JCI66827","volume":"123","author":"TI Kam","year":"2013","unstructured":"Kam TI, Song S, Gwon Y, Park H, Yan JJ, Im I, Choi JW, Choi TY, Kim J, Song DK, Takai T, Kim YC, Kim KS, Choi SY, Choi S, Klein WL, Yuan J, Jung YK (2013) FcgammaRIIb mediates amyloid-beta neurotoxicity and memory impairment in Alzheimer\u2019s disease. J Clin Invest 123:2791\u20132802. https:\/\/doi.org\/10.1172\/JCI66827","journal-title":"J Clin Invest"},{"key":"4379_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1034\/j.1600-079x.2002.1o839.x","volume":"32","author":"YX Shen","year":"2002","unstructured":"Shen YX, Xu SY, Wei W, Wang XL, Wang H, Sun X (2002) Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25\u201335. J Pineal Res 32:163\u2013167. https:\/\/doi.org\/10.1034\/j.1600-079x.2002.1o839.x","journal-title":"J Pineal Res"},{"key":"4379_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04523-8","author":"J Jia","year":"2024","unstructured":"Jia J, Liu H, Sun L, Xu Y, Zeng X (2024) Correction: Thioredoxin-1 protects neurons through inhibiting NLRP1-Mediated neuronal pyroptosis in models of Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04523-8","journal-title":"Mol Neurobiol"},{"key":"4379_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R, Mancuso R, Clerici M (2016) The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol Neurodegener 11:23. https:\/\/doi.org\/10.1186\/s13024-016-0088-1","journal-title":"Mol Neurodegener"},{"key":"4379_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wise L, Fukuchi KI (2020) TLR4 Cross-Talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front Immunol 11:724. https:\/\/doi.org\/10.3389\/fimmu.2020.00724","journal-title":"Front Immunol"},{"key":"4379_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-021-02329-2","volume":"18","author":"W Rui","year":"2021","unstructured":"Rui W, Xiao H, Fan Y, Ma Z, Xiao M, Li S, Shi J (2021) Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer\u2019s disease. J Neuroinflammation 18:280. https:\/\/doi.org\/10.1186\/s12974-021-02329-2","journal-title":"J Neuroinflammation"},{"key":"4379_CR26","doi-asserted-by":"publisher","unstructured":"McGill Percy KC, Liu Z, Qi X (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease: Guiding the path to targeted therapies. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00525. Neurotherapeutics:e00525","DOI":"10.1016\/j.neurot.2025.e00525"},{"key":"4379_CR27","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1111\/jcmm.16984","volume":"25","author":"C Han","year":"2021","unstructured":"Han C, Hu Q, Yu A, Jiao Q, Yang Y (2021) Mafenide derivatives inhibit neuroinflammation in Alzheimer\u2019s disease by regulating pyroptosis. J Cell Mol Med 25:10534\u201310542. https:\/\/doi.org\/10.1111\/jcmm.16984","journal-title":"J Cell Mol Med"},{"key":"4379_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M, Dias D, Sebastiao AM, Valente CA (2021) NLRP3 inflammasome: A starring role in Amyloid-beta- and Tau-Driven pathological events in Alzheimer\u2019s disease. J Alzheimers Dis 83:939\u2013961. https:\/\/doi.org\/10.3233\/JAD-210268","journal-title":"J Alzheimers Dis"},{"key":"4379_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Latz E, Buee L, Heneka MT (2019) NLRP3 inflammasome activation drives Tau pathology. Nature 575:669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"key":"4379_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857\u2013865. https:\/\/doi.org\/10.1038\/ni.1636","journal-title":"Nat Immunol"},{"key":"4379_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, Schroder K (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome Inhibition. Nat Chem Biol 15:556\u2013559. https:\/\/doi.org\/10.1038\/s41589-019-0277-7","journal-title":"Nat Chem Biol"},{"key":"4379_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jnc.14945","volume":"155","author":"A Luciunaite","year":"2020","unstructured":"Luciunaite A, McManus RM, Jankunec M, Racz I, Dansokho C, Dalgediene I, Schwartz S, Brosseron F, Heneka MT (2020) Soluble Abeta oligomers and protofibrils induce NLRP3 inflammasome activation in microglia. J Neurochem 155:650\u2013661. https:\/\/doi.org\/10.1111\/jnc.14945","journal-title":"J Neurochem"},{"key":"4379_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain Behav Immun"},{"key":"4379_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Brone B, Huaux F, Octave JN, Terwel D, Dewachter I (2019) Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol 137:599\u2013617. https:\/\/doi.org\/10.1007\/s00401-018-01957-y","journal-title":"Acta Neuropathol"},{"key":"4379_CR35","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/cns.14219","volume":"29","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang Y, Pan J, Cao J, Sun X, Li X, Zhang L, Qin C (2023) Degradation of NLRP3 by p62-dependent-autophagy improves cognitive function in Alzheimer\u2019s disease by maintaining the phagocytic function of microglia. CNS Neurosci Ther 29:2826\u20132842. https:\/\/doi.org\/10.1111\/cns.14219","journal-title":"CNS Neurosci Ther"},{"key":"4379_CR36","doi-asserted-by":"publisher","first-page":"105255","DOI":"10.1016\/j.bioorg.2021.105255","volume":"115","author":"Y Bai","year":"2021","unstructured":"Bai Y, Liu D, Zhang H, Wang Y, Wang D, Cai H, Wen H, Yuan G, An H, Wang Y, Shi T, Wang Z (2021) N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer\u2019s disease with neuroprotective effects. Bioorg Chem 115:105255. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105255","journal-title":"Bioorg Chem"},{"key":"4379_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.11.004","volume":"536","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo S, Hu D, Dong X, Meng Z, Jiang Y, Feng Z, Zhou W, Song W (2024) Enhanced Gasdermin-E-mediated pyroptosis in Alzheimer\u2019s disease. Neuroscience 536:1\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.11.004","journal-title":"Neuroscience"},{"key":"4379_CR38","doi-asserted-by":"publisher","first-page":"117043","DOI":"10.1016\/j.lfs.2019.117043","volume":"239","author":"N Zhao","year":"2019","unstructured":"Zhao N, Sun C, Zheng M, Liu S, Shi R (2019) Amentoflavone suppresses amyloid beta1-42 neurotoxicity in Alzheimer\u2019s disease through the Inhibition of pyroptosis. Life Sci 239:117043. https:\/\/doi.org\/10.1016\/j.lfs.2019.117043","journal-title":"Life Sci"},{"key":"4379_CR39","doi-asserted-by":"publisher","first-page":"109618","DOI":"10.1016\/j.biopha.2019.109618","volume":"121","author":"Y Li","year":"2020","unstructured":"Li Y, Xu P, Shan J, Sun W, Ji X, Chi T, Liu P, Zou L (2020) Interaction between hyperphosphorylated Tau and pyroptosis in forskolin and streptozotocin induced AD models. Biomed Pharmacother 121:109618. https:\/\/doi.org\/10.1016\/j.biopha.2019.109618","journal-title":"Biomed Pharmacother"},{"key":"4379_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42826-023-00184-1","volume":"39","author":"R Dhapola","year":"2023","unstructured":"Dhapola R, Kumari S, Sharma P, HariKrishnaReddy D (2023) Insight into the emerging and common experimental in-vivo models of Alzheimer\u2019s disease. Lab Anim Res 39:33. https:\/\/doi.org\/10.1186\/s42826-023-00184-1","journal-title":"Lab Anim Res"},{"key":"4379_CR41","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido TC (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36:2473\u20132487. https:\/\/doi.org\/10.15252\/embj.201797397","journal-title":"EMBO J"},{"key":"4379_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-020-00415-2","volume":"15","author":"T Natunen","year":"2020","unstructured":"Natunen T, Martiskainen H, Marttinen M, Gabbouj S, Koivisto H, Kemppainen S, Kaipainen S, Takalo M, Svobodova H, Leppanen L, Kemilainen B, Ryhanen S, Kuulasmaa T, Rahunen E, Juutinen S, Makinen P, Miettinen P, Rauramaa T, Pihlajamaki J, Haapasalo A, Leinonen V, Tanila H, Hiltunen M (2020) Diabetic phenotype in mouse and humans reduces the number of microglia around beta-amyloid plaques. Mol Neurodegener 15:66. https:\/\/doi.org\/10.1186\/s13024-020-00415-2","journal-title":"Mol Neurodegener"},{"key":"4379_CR43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/0269881119855987","volume":"33","author":"S Abad","year":"2019","unstructured":"Abad S, Ramon-Duaso C, Lopez-Arnau R, Folch J, Pubill D, Camarasa J, Camins A, Escubedo E (2019) Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe\/PS1dE9 mice. J Psychopharmacol 33:1170\u20131182. https:\/\/doi.org\/10.1177\/0269881119855987","journal-title":"J Psychopharmacol"},{"key":"4379_CR44","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.neuron.2022.03.034","volume":"110","author":"WJ Lee","year":"2022","unstructured":"Lee WJ, Brown JA, Kim HR, La Joie R, Cho H, Lyoo CH, Rabinovici GD, Seong JK, Seeley WW, Alzheimer\u2019s Disease Neuroimaging I (2022) Regional Abeta-tau interactions promote onset and acceleration of Alzheimer\u2019s disease Tau spreading. Neuron 110:1932\u20131943. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.034. e1935","journal-title":"Neuron"},{"key":"4379_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41593-018-0070-z","volume":"21","author":"HIL Jacobs","year":"2018","unstructured":"Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA (2018) Structural tract alterations predict downstream Tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424\u2013431. https:\/\/doi.org\/10.1038\/s41593-018-0070-z","journal-title":"Nat Neurosci"},{"key":"4379_CR46","doi-asserted-by":"publisher","first-page":"eabl8809","DOI":"10.1126\/sciadv.abl8809","volume":"8","author":"K Stefanoska","year":"2022","unstructured":"Stefanoska K, Gajwani M, Tan ARP, Ahel HI, Asih PR, Volkerling A, Poljak A, Ittner A (2022) Alzheimer\u2019s disease: ablating single master site abolishes Tau hyperphosphorylation. Sci Adv 8:eabl8809. https:\/\/doi.org\/10.1126\/sciadv.abl8809","journal-title":"Sci Adv"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04379-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T03:59:55Z","timestamp":1745553595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04379-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04379-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Ethics Committee of the Second Hospital of Shandong University approved this study in accordance with the National Institutes of Health guidelines for the Care and Use of Laboratory Animals (Ethics approval No. KYLL-2021(KJ)A-0195).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"135"}}